Is lenvatinib in combination with transarterial chemoembolization benefit for unresectable hepatocellular carcinoma (uHCC)? The age interference needs to be eliminated.
作者信息
Li Sai, Li Yong
机构信息
Interventional Radiology Center, Department of Radiology, The Third Xiangya Hospital of Central South Hospital, Changsha, 410005, Hunan, China.
Interventional Radiology Center, Department of Radiology, Xiangya Hospital Central South University, Changsha, 410005, Hunan, China.
出版信息
Hepatol Int. 2024 Apr;18(2):704-705. doi: 10.1007/s12072-023-10611-z. Epub 2023 Nov 9.
PMID:37943415
Abstract
摘要
Zotero 插件